Gastrointestinal Cancer News

In a new study, Medicare beneficiaries with advanced hepatocellular carcinoma treated with Nexavar only had a median survival of 3 months.

James P. Allison, PhD, chair of the department of immunology and executive director of the immunotherapy platform at the MD Anderson Cancer Center in Houston, highlights new findings emerging from clinical research into the use of immunotherapy to treat various cancers.

Preliminary data from a small randomized study showed light therapy decreased depressive symptoms and normalized circadian rhythms among cancer survivors.

Heather S.L. Jim, PhD, of the health outcomes and behavior program at Moffitt Cancer Center, and colleagues analyzed data from previously published studies that examined spirituality and its association with outcomes among more than 32,000 patients with cancer. They found that patients with higher levels of spiritual well-being reported better emotional, physical and social health.

Women who underwent oophorectomy for benign indications appeared at greater risk for colorectal cancer, according to the results of a population study conducted in Sweden.

Patients with hepatocellular carcinoma seen at a high-volume hospital had improved overall survival vs. patients seen at a low-volume hospital, according to published findings.

Eradication of Helicobacter pylori infection was associated with a reduced incidence of gastric cancer in populations with different levels of gastric cancer risk, according to the results of a systematic review and meta-analysis.

Patients with multiple sclerosis treated with mitoxantrone may face an increased risk for colorectal cancer, according to the results of a retrospective cohort study.

Preoperative chemoprophylaxis safely and effectively decreased the incidence of venous thromboembolism among patients undergoing major cancer surgery, according to the results of a single-center prospective study.

In a case-control study performed among Alaska Natives, hepatitis B surface antigen seroclearance was not associated with a decreased risk for developing hepatocellular carcinoma.